Blog Categories
- Appliances Four
- Athletic Seating
- Auto Helpers
- Automated Stock Rooms
- Chocolate Four
- CuraFlo
- Damaged Goods Dating
- Flood Insurance Four
- Game Addict
- Hi Tech Pest Control
- HVAC Four
- Medical Labels Four
- Mental Health Four
- National CWS
- Promotional Ideas
- Seguros Lara Insurance
- Stem Cell Worx
- The Hidden Truth
- The Last Refuge
- The Mozilla Blog
- Video Editing Four
- Web Design Dev
- Website Development Four
- Windows Blog
There It Is – Study Finds Predominance of Antibody-Resistant SARS-CoV-2 Variants in Vaccine Breakt
[BACK]
Posted On: October 4, 2021
What this study finds is exactly what vaccine developer Geert Vanden Bossche (Belgium) has been predicting. The predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California. [DATA LINK HERE] The California study finds that vaccinated individuals are more susceptible to COVID variant infections than unvaccinated. Geer Vanden Bossche […]
The post There It Is – Study Finds Predominance of Antibody-Resistant SARS-CoV-2 Variants in Vaccine Breakthrough Cases in San Francisco Bay Area appeared first on The Last Refuge.
Re Posted From: There It Is – Study Finds Predominance of Antibody-Resistant SARS-CoV-2 Variants in Vaccine Breakthrough Cases in San Francisco Bay Area
[BACK]
[BACK]Posted On: October 4, 2021
What this study finds is exactly what vaccine developer Geert Vanden Bossche (Belgium) has been predicting. The predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California. [DATA LINK HERE] The California study finds that vaccinated individuals are more susceptible to COVID variant infections than unvaccinated. Geer Vanden Bossche […]
The post There It Is – Study Finds Predominance of Antibody-Resistant SARS-CoV-2 Variants in Vaccine Breakthrough Cases in San Francisco Bay Area appeared first on The Last Refuge.
Re Posted From: There It Is – Study Finds Predominance of Antibody-Resistant SARS-CoV-2 Variants in Vaccine Breakthrough Cases in San Francisco Bay Area